关于我们

关于泰格医药(https://www.tigermedgrp.com/zh/our-company)

愿景和企业文化(https://www.tigermedgrp.com/zh/culture-values)

管理团队(https://www.tigermedgrp.com/zh/leadership)

全球布局(https://www.tigermedgrp.com/zh/global-locations)

企业合规政策(https://www.tigermedgrp.com/zh/corporate-compliance)

主要子公司(https://www.tigermedgrp.com/zh/subsidiaries-joint-ventures)

多元与包容(https://www.tigermedgrp.com/zh/diversity-inclusion)

我们的20年(https://www.tigermedgrp.com/zh/20th-Anniversary)

泰格医药公益基金会(https://www.tigermedgrp.com/zh/Tigermed-Foundation)

泰格全球

泰格欧洲、中东和非洲(https://tigermedemea.com/) 泰格美国(https://tigermedus.com/en/homepage)

媒体与资源

公司新闻(https://www.tigermedgrp.com/zh/media-resources/press-releases) 会议和活动(https://www.tigermedgrp.com/zh/media-resources/events) 泰格洞见(https://www.tigermedgrp.com/zh/media-resources/tigermed-insights) 资源中心(https://www.tigermedgrp.com/zh/media-resources/resource-library) 泰格云课堂(https://www.tigermedgrp.com/zh/media-resources/cloud-classroom)

环境、社会及管治(ESG)(https://www.tigermedgrp.com/zh/esg)

可持续发展 & ESG报告(https://www.tigermedgrp.com/zh/sustainability-esg-report) ESG管理与政策(https://www.tigermedgrp.com/zh/esg-management) 企业责任(https://www.tigermedgrp.com/zh/corporate-responsibility)

泰格医药集团

为全球医药和医疗器械创新企业提供临床研究的全过程专业服务和一站式解决方案。

解决方案

临床前研究(https://www.tigermedgrp.com/zh/solutions/by-phase/preclinical)

早期临床研究(https://www.tigermedgrp.com/zh/solutions/by-phase/early-phase)

II-III 期临床研究(https://www.tigermedgrp.com/zh/solutions/by-phase/Phase-ii-iii-clinical)

上市后研究(https://www.tigermedgrp.com/zh/solutions/by-phase/post-marketing)

真实世界研究(https://www.tigermedgrp.com/zh/solutions/by-phase/real-world-study)

临床前开发(https://www.tigermedgrp.com/zh/solutions/by-phase/preclinical)

药物化学(https://www.tigermedgrp.com/zh/solutions/preclinical-development/medicinal-chemistry) 药物筛选(https://www.tigermedgrp.com/zh/solutions/preclinical-development/compound-screening) 药代动力学(https://www.tigermedgrp.com/zh/solutions/preclinical-development/dmpk) 临床前安评(https://www.tigermedgrp.com/zh/solutions/preclinical-development/safety-toxicology) 生物分析(https://www.tigermedgrp.com/zh/solutions/preclinical-development/bioanalytical) 药学研究(https://www.tigermedgrp.com/zh/solutions/preclinical-development/cmc)

临床开发(https://www.tigermedgrp.com/zh/solutions/clinical-development)

医学撰写(https://www.tigermedgrp.com/zh/solutions/clinical-development/medical-writing) 临床监查(https://www.tigermedgrp.com/zh/solutions/clinical-development/clinical-monitoring) 注册事务(https://www.tigermedgrp.com/zh/solutions/clinical-development/regulatory-affairs) 数据管理和统计分析(https://www.tigermedgrp.com/zh/solutions/clinical-development/data-management-and-statistical-analysis) 临床开发策略(https://www.tigermedgrp.com/zh/solutions/clinical-development/clinical-development-strategy) 去中心化临床试验 (DCTs)(https://www.tigermedgrp.com/zh/solutions/Decentralized-Clinical-Trials) SMO 现场管理(https://www.tigermedgrp.com/zh/solutions/clinical-development/site-management) 医疗器械 / 体外诊断产品(https://www.tigermedgrp.com/zh/solutions/clinical-development/medical-device-ivd) 国际多中心临床试验(MRCT)(https://www.tigermedgrp.com/zh/solutions/clinical-development/multi-region-clinical-trial-mrct) 疫苗临床试验(https://www.tigermedgrp.com/zh/solutions/clinical-development/vaccine-clinical-trial)

一体化平台与服务(https://www.tigermedgrp.com/zh/solutions/integrated-capabilities)

独立影像评估(https://www.tigermedgrp.com/zh/solutions/integrated-capabilities/medical-imaging) 药物警戒(https://www.tigermedgrp.com/zh/solutions/integrated-capabilities/pharmacovigilance) 医学翻译(https://www.tigermedgrp.com/zh/solutions/integrated-capabilities/medical-translation) 质量保证(https://www.tigermedgrp.com/zh/solutions/integrated-capabilities/quality-assurance) GMP合规咨询(https://www.tigermedgrp.com/zh/solutions/integrated-capabilities/gmp-consulting) 现场服务(FSP)(https://www.tigermedgrp.com/zh/solutions/integrated-capabilities/functional-service-provider) 中心实验室(https://www.tigermedgrp.com/zh/solutions/integrated-capabilities/central-laboratories) 参与者管理(https://www.tigermedgrp.com/zh/solutions/clinical-development/participant-management) 临床信息管理系统(https://www.tigermedgrp.com/zh/solutions/integrated-capabilities/edc-system) 远程随访中心(https://www.tigermedgrp.com/zh/solutions/integrated-capabilities/Remote-Follow-up-Center) 科研服务(https://www.tigermedgrp.com/zh/solutions/Academic-Services) 知识产权(https://www.tigermedgrp.com/zh/solutions/TAYA-IP)

治疗领域

GLP-1受体激动剂(https://www.tigermedgrp.com/zh/solutions/GLP-1-RA) 细胞与基因疗法(https://www.tigermedgrp.com/zh/solutions/clinical-development/cell-and-gene-therapy) 核药(https://www.tigermedgrp.com/zh/solutions/radiopharmaceutical) 肿瘤(https://www.tigermedgrp.com/zh/solutions/therapeutic-expertise/oncology) 抗感染(https://www.tigermedgrp.com/zh/solutions/therapeutic-expertise/infectious-diseases) 血液(https://www.tigermedgrp.com/zh/solutions/therapeutic-expertise/hematology) 心脑血管(https://www.tigermedgrp.com/zh/solutions/therapeutic-expertise/cardiovascular) 内分泌(https://www.tigermedgrp.com/zh/solutions/therapeutic-expertise/endocrinology) 自身免疫(https://www.tigermedgrp.com/zh/solutions/therapeutic-expertise/rheumatology) 中枢神经(https://www.tigermedgrp.com/zh/solutions/therapeutic-expertise/central-nervous-system) 消化(https://www.tigermedgrp.com/zh/solutions/therapeutic-expertise/gastroenterology) 眼科(https://www.tigermedgrp.com/zh/solutions/therapeutic-expertise/ophthalmology)

加入我们

泰格人的故事(https://www.tigermedgrp.com/zh/careers/working-at-tigermed) 人才成长与发展(https://www.tigermedgrp.com/zh/careers/talent-development) 享受在泰格的每一天(https://www.tigermedgrp.com/zh/careers/enjoy-your-life-with-tigermed) 加入泰格医药(中国)(https://www.tigermedgrp.com/zh/careers/join-tigermed) 加入泰格医药(全球)(https://www.tigermedgrp.com/zh/careers/join-tigermed-global)

我们的全球布局 了解我们在亚洲、北美、欧洲、南美、非洲的分支机构(https://www.tigermedgrp.com/zh/global-locations) 我们的工作机会 查看我们在全球的职位信息(https://tigermed.zhiye.com/)

投资者关系

公司治理(https://www.tigermedgrp.com/zh/investors/corporate-governance) 财务报告和演示材料(https://www.tigermedgrp.com/zh/investors/financial-reports-and-presentations) 公司公告(https://www.tigermedgrp.com/zh/investors/announcements) 招股文件(https://www.tigermedgrp.com/zh/investors/prospectus) 投资者联系方式(0571-89986795)(https://www.tigermedgrp.com/zh/investors/investor-contact)

泰格医药 2026年中期业绩演示材料 查看泰格医药 2026年中期业绩演示材料(https://www.tigermedgrp.com/files/73b7cf506e573ff30be59c81e489527f.pdf)

泰格医药:2026 年半年度报告(https://www.tigermedgrp.com/files/2989264f62ec5e6e0345e4150471ab65.pdf)

联系我们

客户服务中心(https://www.tigermedgrp.com/zh/contact/client-service-center) 业务咨询/RFP(https://www.tigermedgrp.com/zh/contact/business-enquiry) 媒体与投资者咨询(https://www.tigermedgrp.com/zh/contact/media-investors-enquiry) 合规疑虑(https://www.tigermedgrp.com/zh/contact/compliance-concern)

业务咨询/RFP 邮箱:marketing@tigermedgrp.com(https://www.tigermedgrp.com/zh/contact/business-enquiry) 客户服务中心 邮箱:clientservice@tigermedgrp.com(https://www.tigermedgrp.com/zh/contact/client-service-center)

媒体与投资者咨询 邮箱:PR@tigermedgrp.com(https://www.tigermedgrp.com/zh/contact/media-investors-enquiry) 合规疑虑 邮箱:compliance.officer@tigermedgrp.com(https://www.tigermedgrp.com/zh/contact/compliance-concern)

快速链接

临床前研究(https://www.tigermedgrp.com/zh/search?kw=临床前研究) 早期临床研究(https://www.tigermedgrp.com/zh/search?